ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1363	National Cancer Institute	Html	en	Male Breast Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of male breast cancer.	AI vs 0.370903 mismatch repair mutations 0.369221 Eggemann et al. 0.365773 female breast cancer 0.551031 breast cancer patients. 0.466631 GnRH analogue 0.380989 PDQ cancer information 0.414389 Information About Breast 0.42794 Preoperative Systemic Therapy 0.38272 randomized phase 0.368125 tamoxifen 0.45543 clinical trial 0.36672 Intraductal cancer 0.367134 hormone-releasing hormone 0.373589 Breast Cancer section 0.560693 systemic therapy 0.39727 Postoperative Systemic Therapy 0.381557 AI therapy 0.401771 PDQ Adult Treatment 0.387754 hormonal therapy 0.380314 retrospective analysis 0.368006 gonadotropin-releasing hormone 0.373142 hormone receptor-positive breast 0.492818 breast cancer. 0.41194 German Breast Group 0.488303	et al. 0.433842 Comprehensive Cancer Database 0.381494 nonpolyposis colorectal cancer 0.384245 stage breast cancer 0.454368 Ding et al. 0.368736 male breast cancer 0.671805 Lymph node involvement 0.37157 Early/Localized/Operable Breast Cancer 0.46567 median follow-up 0.370308 ductal cancer 0.367207 Breast Cancer Treatment 0.527076 PDQ Editorial Boards 0.382108 pdq summary 0.467559 adjuvant endocrine therapy 0.440604 early-stage hormone 0.372333 breast cancer 0.962266 adjuvant treatment options 0.385121 AJCC Stage Groupings 0.374688 Zagouri et al. 0.367325 male breast cancers 0.446407 common tumor type. 0.372879 specific treatment modalities 0.365164 analogue versus AI 0.45406 receptor-positive breast cancer 0.49928	CLICK HERE
1419	National Cancer Institute	Html	en	Lung Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for lung cancer.	lung cancer screening 0.756773 initial screening test 0.3898 LDCT lung cancer 0.431859 sputum cytology 0.442562 U.K. Lung Cancer 0.42482 negative screening test 0.411746 lung cancer 0.9987 lung cancer mortality. 0.430481 current smokers 0.386204 intense screening regimen 0.386147 Early Lung Cancer 0.463536 chest imaging 0.420806 positive screening result 0.397336 lung abnormalities 0.397732 excess lung cancer 0.416122 Lung Screening Trial 0.503515 group 0.383474 intervention arm 0.382743 lung cancer problem 0.42431 positive screening test 0.414453 screening phase 0.386735 lung cancers 0.45033 major lung abnormality 0.402566 LDCT screening 0.417092 lung cancer cases 0.428353	randomized Danish Lung 0.39566 positive screening tests 0.398319 chest radiographic screening 0.412733 cancer screening program 0.414425 lung component 0.385589 Danish Lung Cancer 0.447818 Screening pilot trial 0.393797 Lung Cancer Action 0.443317 participants 0.389736 National Lung Screening 0.500437 Lung Cancer Detection 0.423833 CT screening program 0.391863 Randomized Lung Cancer 0.430455 small lung cancers 0.401362 screening exams 0.383361 lung cancer. 0.390552 lung cancer deaths 0.457228 PLCO Cancer Screening 0.408534 lung cancer death 0.470333 Mayo Lung Project 0.426524 screening test 0.418941 lung cancer mortality 0.632713 lung cancer incidence 0.423847 Cancer Screening Trial 0.513616	CLICK HERE
1428	National Cancer Institute	Html	null	Retinoblastoma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of retinoblastoma in children.			CLICK HERE
1542	National Cancer Institute	Html	en	Uterine Sarcoma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of uterine sarcomas.	cancer treatment 0.326283 cancer spreads 0.27392 body 0.30595 PDQ cancer information 0.340432 clinical trial search 0.337812 uterus 0.36876 metastatic uterine sarcoma 0.28805 clinical trials 0.632813 cancer information summary 0.313263 clinical trial 0.463679 Transvaginal ultrasound exam 0.270971 patients 0.291529 Recurrent uterine sarcoma 0.312941 total abdominal hysterectomy 0.33979 treatment clinical trial 0.271689 NCI PDQ cancer 0.280198 Treatment Option Overview 0.316082 radiation therapy 0.397408 Treatment Editorial Board 0.278942 General information 0.276617 general cancer information 0.27165 treatment 0.476479 uterine sarcoma cells 0.294562 NCI-supported cancer 0.289424 cancer cells 0.449324	Cancer Information Service 0.272134 Uterine Sarcoma Treatment 0.298886 Option Overview section 0.306678 Uterine Cancer Home 0.286123 treatment clinical trials 0.296817 National Cancer Institute 0.35406 new treatment 0.296864 uterine sarcoma 0.941913 Uterine Sarcoma section 0.285791 diagnose uterine sarcoma 0.300059 PDQ summary 0.281429 uterine sarcoma spreads 0.28676 cancer clinical trials 0.348942 stage 0.302932 Endometrial Cancer Treatment 0.295433 high-energy sound waves 0.275392 fallopian tubes 0.310914 Tissue Sarcoma Treatment 0.291575 treatment options 0.275101 cancer information summaries 0.270428 comprehensive cancer information 0.27068 cancer 0.782046 information 0.353338 standard treatment 0.299992	CLICK HERE
1849	National Cancer Institute	Html	es	Tratamiento del cáncer de próstata (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de próstata.	Compton CC 0.32822 preoperative nomogram 0.351745 outcome after 0.326979 progression after psa 0.331315 Albertsen PC 0.319652 prostate specific 0.36016 clinically localized 0.351298 Kabalin JN 0.319448 American Cancer Society 0.354812 Radical prostatectomy versus 0.362604 Eastham JA 0.338512 versus watchful waiting 0.321163 following radical prostatectomy 0.340792 PSA anormal 0.32618 7th ed 0.328183 Radiat Oncol Biol 0.401027 Estados Unidos 0.34545 Natl Cancer Inst 0.962766 cancer staging 0.41957 men with 0.323828 Stamey TA 0.333393 Radical prostatectomy treated 0.32026 Union Against Cancer 0.327902 versus gleason 0.324714 prostate biopsy 0.325976	with psa testing 0.327026 ecografía transrectal 0.331137 prostate with radiotherapy 0.319235 Cancer Facts 0.330577 gammagrafía ósea 0.32132 radical prostatectomy 0.783813 after radical prostatectomy 0.482799 Cancer Staging Manual 0.40851 recurrence after 0.340439 New York 0.323092 Clin Oncol 0.387513 predict pathological stage 0.323561 Oncol Biol Phys 0.404255 Oncology Consensus Panel 0.323099 Kattan MW 0.336259 systematic review 0.320343 with clinically localized 0.323887 Byrd DR 0.326227 American Joint Committee 0.318729 Partin AW 0.341859 transrectal ultrasound guided 0.325554 AJCC Cancer Staging 0.413497 Edge SB 0.328269 PSA following 0.325762	CLICK HERE
1939	National Cancer Institute	Html	es	Adaptación al cáncer: ansiedad y sufrimiento (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de las difíciles respuestas emocionales que se presentan en muchos de los pacientes con cáncer. Este sumario se enfoca en asuntos de la adaptación normal, alteración psicosocial y trastornos de adaptación.	La espiritualidad 0.829227 siguientes aspectos 0.951689 intensa ansiedad 0.886965 siguientes tipos 0.835996 largo plazo 0.911949 ¿Qué efectos 0.840354 siguientes períodos 0.85698 siguientes síntomas 0.824791 siguientes riesgos 0.776419 Visuals Online 0.784027 Physician Data 0.774429 siguientes problemas 0.817253	siguientes factores 0.894404 Mucha transpiración 0.807275 resultados correctos 0.846693 libre uso 0.789 siguientes situaciones 0.941031 Data Query 0.774207 siguientes características 0.904197 Cancer Institute 0.786402 página manejo 0.784108 suficiente dinero 0.80221 siguientes sumarios 0.945414 usa compulsiones 0.805006	CLICK HERE
2013	National Cancer Institute	Html	es	Aspectos generales de los exámenes de detección del cáncer (PDQ®)–Versión para pacientes	Información sobre la medición de la eficacia de los exámenes de detección del cáncer y la evaluación de la solidez de las pruebas obtenidas en estudios de investigación de detección del cáncer.	suficiente información 0.640426 riesgos.Algunos exámenes 0.948845 posibles factores 0.658466 End Results 0.782283 siguientes aspectos 0.657281 cabo ensayos 0.656668 ¿Los exámenes 0.83489 siguientes tipos 0.726625 efecto secundario adverso 0.681584 cuánto tiempo 0.658052 grupo pacientes 0.645515 información ayuda 0.635388 National Cancer Institute 0.643177	siguientes riesgos 0.629124 Instituto Nacional 0.984309 antecedentes familiares 0.663533 suficientes pruebas 0.65243 Physician Data Query 0.768953 Estados Unidos 0.927922 menor tiempo 0.639093 única razón 0.651582 posibles beneficios 0.675509 determinada enfermedad 0.640319 cuáles pruebas 0.82218 términos riesgo 0.746808 PDQ Aspectos 0.65214	CLICK HERE
3675	National Cancer Institute	Html	en	Data Submission Under the Genomic Data Sharing (GDS) Policy	Information for intramural, extramural, and non-NIH funded investigators looking to submit study data under the Genomic Data Sharing (GDS) Policy.	data instruments 0.389578 Different submission requirements 0.358856 Different data types 0.458311 data 0.914172 N/A Arrays 0.352863 Institutional Certification 0.390929 data use limitations 0.365334 phenotype data 0.455331 DNA sequence data 0.507348 clinical information 0.351464 N/A .BAM Arrays 0.717463 common data elements 0.45555 NCI intramural research 0.372571 RNAseq data 0.381683 submission process 0.341088 SNP array data 0.440533 Data reuse 0.406127 genomic data 0.788599 genomic program administrator 0.366093 controlled-access genomic data 0.507551 Raw data 0.388186 bisulfite sequencing data 0.488737 data sharing plan 0.431561 scientific review 0.378953	basis N/A .TXT 0.57172 GWAS data 0.384745 data standards 0.487591 published table 0.34424 human genomic data 0.471234 additional research questions 0.363874 data processing 0.449487 GDS policy-covered research 0.360223 human sample data 0.554048 GDS website 0.358009 DNA methylation data 0.435253 NIH data repositories 0.466908 minimizes potential errors 0.345345 data generation 0.367981 Developing Data Sharing 0.429887 exposure data 0.441991 well-documented data standards 0.480779 genomic data—such 0.394593 data submission 0.621641 data release 0.391289 NIH National Center 0.357378 genomic data submissions 0.597871 N/A .BAM NGS 0.52976	CLICK HERE
16713	National Cancer Institute	Html	es	Iniciativa de Respuestas Excepcionales: Preguntas y respuestas	El Instituto Nacional del Cáncer (NCI) emprendió la Iniciativa de Respuestas Excepcionales a fin de entender la base molecular de los tumores en pacientes de cáncer que responden en forma excepcional al tratamiento, principalmente quimioterapia.	Exceptional Responders 0.786989 suficiente información 0.61563 Sequencing Identifies 0.586522 poderosa técnica 0.577603 tejido no puede usarse para otras 0.723672 siguientes criterios 0.611344 llamado data access request 0.624892 ARN mensajero 0.581431 Everolimus Sensitivity 0.593577 suficiente ácido 0.633822 Genome Sequencing 0.743091 suficiente tejido 0.888254 genes tsc1 0.601267 datos dbGAP 0.580415 estudio piloto 0.664379 tejido fijo en formol 0.691726 Exceptional Responders Data 0.636284	Exceptional Responders Initiative 0.702067 consentimiento apropiado para investigaciones 0.678722 fármacos similares. El estudio 0.741131 Instituto Nacional 0.57833 gen tsc1 0.738554 Trials Support Unit 0.638511 descubrimientos prometedores 0.585883 datos clínicos a medidata 0.649717 Revisión Central de Adultos 0.624848 extensa experiencia 0.580712 requiere varios pasos 0.583341 pacientes con respuestas 0.618767 centro biospecimen core 0.880872 tumores sólidos 0.758056 enfermedad y el 0.583796 aun pacientes 0.751408	CLICK HERE
16861	National Cancer Institute	Html	es	Terapia Gerson (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de la terapia Gerson como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	múltiples detalles 0.301338 Centro Nacional 0.302469 New Hampshire Avenue 0.301732 Drug Administration 0.301078 NCI Best Case 0.303308 Max B 0.30156 datos bibliográficos pubmed 0.30187 cuerpo suficientes vitaminas 0.303678 Vitaminas A 0.301419 siguientes preguntas 0.30102 National Cancer Institute 0.302137 siguientes riesgos 0.301292 vitamina b12 0.301563 alto contenido 0.301449 Instituto Nacional 0.314894 Gerson Research Organization 0.308778 Salud Complementaria 0.303978 Visuals Online 0.301269	complementarias revisa 0.301833 PDQ Terapia Gerson 0.311186 Physician Data Query 0.307427 comidas vegetarianas 0.301548 coenzima q10 0.304748 Estados Unidos 0.316664 enzimas pancreáticas 0.305305 libre uso 0.301348 página manejo 0.301179 ¿El tratamiento 0.302348 suficiente potasio 0.301916 ¿Los beneficios 0.301092 juntos cam 0.301043 numerosos detalles 0.301552 Series Program 0.301073 terapia gerson 0.988974 medicina complementaria 0.349955	CLICK HERE